⌘K

Login Start Free

Home/Filings/144/0001140361-25-018460

144//SEC Filing

BridgeBio Pharma, Inc. 144

Accession 0001140361-25-018460

CIK 0001780408other

View on SEC.gov Company Profile

Filed

May 11, 8:00 PM ET

Accepted

May 12, 9:46 PM ET

Size

6.6 KB

Accession

0001140361-25-018460

Documents

1 file

144
primary_doc.xmlPrimary

Issuer

KKR Genetic Disorder L.P.

CIK 0001780408

Entity typeother

IncorporatedDE

Related Parties

1

filerCIK 0001780408

Filing Metadata

Form type: 144
Filed: May 11, 8:00 PM ET
Accepted: May 12, 9:46 PM ET
Size: 6.6 KB

View on SEC.gov